Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiac fibrosis
Nikolaos G. Frangogiannis
Cardiovascular Research (2020) Vol. 117, Iss. 6, pp. 1450-1488
Open Access | Times Cited: 717

Showing 26-50 of 717 citing articles:

Single-cell transcriptome atlas of the human corpus cavernosum
Liangyu Zhao, Sha Han, Hengchuan Su, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55
Reduction of Cardiac Fibrosis by Interference With YAP-Dependent Transactivation
Gloria Garoffolo, Manuel Casaburo, Francesco Amadeo, et al.
Circulation Research (2022) Vol. 131, Iss. 3, pp. 239-257
Open Access | Times Cited: 54
Calycosin reduces myocardial fibrosis and improves cardiac function in post-myocardial infarction mice by suppressing TGFBR1 signaling pathways
Guang‐Hong Chen, Honglin Xu, Tong Xu, et al.
Phytomedicine (2022) Vol. 104, pp. 154277-154277
Closed Access | Times Cited: 51
Based on network pharmacology and in vitro experiments to prove the effective inhibition of myocardial fibrosis by Buyang Huanwu decoction
Tianyue Wang, Xinyu Jiang, Yanmin Ruan, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 13767-13783
Open Access | Times Cited: 50
Remodeling and Fibrosis of the Cardiac Muscle in the Course of Obesity—Pathogenesis and Involvement of the Extracellular Matrix
Jagoda Kruszewska, Agnieszka Cudnoch‐Jędrzejewska, Katarzyna Czarzasta
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4195-4195
Open Access | Times Cited: 49
Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors
Takahiko Akiyama, Tadahito Yasuda, Tomoyuki Uchihara, et al.
Cancer Research (2022) Vol. 83, Iss. 5, pp. 753-770
Open Access | Times Cited: 49
Cardiac Remodeling in Heart Failure: Role of Pyroptosis and Its Therapeutic Implications
Ruoning Chai, Wenjing Xue, Shuqing Shi, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 43
Role of puerarin in pathological cardiac remodeling: A review
Jiayu Lv, Shuqing Shi, Bingxuan Zhang, et al.
Pharmacological Research (2022) Vol. 178, pp. 106152-106152
Closed Access | Times Cited: 41
Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment
Aydin Huseynov, İbrahim Akın, Daniel Duerschmied, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 389-389
Open Access | Times Cited: 39
Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells
Xuefeng Qu, Bingzhong Zhai, Wenli Hu, et al.
European Journal of Nutrition (2022) Vol. 61, Iss. 4, pp. 1823-1836
Open Access | Times Cited: 38
Cardiac Remodeling After Myocardial Infarction: Functional Contribution of microRNAs to Inflammation and Fibrosis
Fahimeh Varzideh, Urna Kansakar, Kwame Donkor, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 38
Modeling Heart Diseases on a Chip: Advantages and Future Opportunities
Omar Mourad, Ryan Yee, Mengyuan Li, et al.
Circulation Research (2023) Vol. 132, Iss. 4, pp. 483-497
Closed Access | Times Cited: 36
SGLT1: A Potential Drug Target for Cardiovascular Disease
Mengnan Zhao, Na Li, Hong Zhou
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 2011-2023
Open Access | Times Cited: 36
Single-cell RNA-seq of heart reveals intercellular communication drivers of myocardial fibrosis in diabetic cardiomyopathy
Wei Li, Xinqi Lou, Yingjie Zha, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 34
METTL3 boosts mitochondrial fission and induces cardiac fibrosis by enhancing LncRNA GAS5 methylation
Bin Tu, Kai Song, Yang Zhou, et al.
Pharmacological Research (2023) Vol. 194, pp. 106840-106840
Open Access | Times Cited: 34
Crosstalk between oxidative stress and epigenetic marks: New roles and therapeutic implications in cardiac fibrosis
Zhiyan Liu, Kai Song, Bin Tu, et al.
Redox Biology (2023) Vol. 65, pp. 102820-102820
Open Access | Times Cited: 33
The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools
Kuo‐Li Pan, Yung‐Chien Hsu, Shih‐Tai Chang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8604-8604
Open Access | Times Cited: 32
Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias
Art Schuermans, Caitlyn Vlasschaert, Victor Nauffal, et al.
European Heart Journal (2023) Vol. 45, Iss. 10, pp. 791-805
Open Access | Times Cited: 29
Injectable decellularized extracellular matrix hydrogel loaded with exosomes encapsulating curcumin for prevention of cardiac fibrosis after myocardial infarction
Yuanyuan Wang, Jingjing Wang, Chunxia Liu, et al.
Journal of Material Science and Technology (2023) Vol. 167, pp. 50-58
Closed Access | Times Cited: 28
Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
Yanan Cheng, Yan Wang, Ruili Yin, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 27
Fibrosis in Pathology of Heart and Kidney: From Deep RNA-Sequencing to Novel Molecular Targets
Felix Schreibing, Teresa M Anslinger, Rafael Kramann
Circulation Research (2023) Vol. 132, Iss. 8, pp. 1013-1033
Closed Access | Times Cited: 27
Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice
Xi Lou, Yawen Tang, Lei Ye, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 4, pp. 1062-1076
Open Access | Times Cited: 26
Ischemic cardiomyopathy: epidemiology, pathophysiology, outcomes, and therapeutic options
Paola Pastena, Jesse Frye, Carson Ho, et al.
Heart Failure Reviews (2023) Vol. 29, Iss. 1, pp. 287-299
Closed Access | Times Cited: 25
Signaling Pathways and Potential Therapeutic Strategies in Cardiac Fibrosis
Alexandrine Foucault‐Bertaud, Ahmad Joshkon, Xavier Heim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1756-1756
Open Access | Times Cited: 24
Progress and prospect of nanotechnology for cardiac fibrosis treatment
Samantha L. Gaytan, Elfa Beaven, Shrikanth S. Gadad, et al.
Deleted Journal (2023) Vol. 1, Iss. 4
Open Access | Times Cited: 24

Scroll to top